Stay updated on Valoctocogene Roxaparvovec in Hemophilia A Clinical Trial
Sign up to get notified when there's something new on the Valoctocogene Roxaparvovec in Hemophilia A Clinical Trial page.

Latest updates to the Valoctocogene Roxaparvovec in Hemophilia A Clinical Trial page
- Check4 days agoChange DetectedAdded Hereditary factor VIII deficiency disease reference and a Genetics Center resources link (Genetic and Rare Diseases Information Center) to the page.SummaryDifference0.2%

- Check11 days agoChange DetectedRemoved the disease term Hemophilia A from the study description/keywords and deleted the Genetic and Rare Diseases Information Center resource from the Resources section.SummaryDifference0.2%

- Check18 days agoChange DetectedAdded revision note v3.5.0 and removed revision v3.4.3 from the page history.SummaryDifference0.1%

- Check26 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3. No substantive changes to study details or procedures are evident in the screenshots.SummaryDifference0.1%

- Check54 days agoChange DetectedNew site revision added: Revision: v3.4.2. The previously displayed notice about government funding lapse and the older Revision: v3.4.1 text were removed.SummaryDifference0.5%

- Check61 days agoChange DetectedA new site-wide notice about a lapse in government funding was added, and the page revision shows version 3.4.1 (replacing 3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Valoctocogene Roxaparvovec in Hemophilia A Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Valoctocogene Roxaparvovec in Hemophilia A Clinical Trial page.